Filing Details

Accession Number:
0001209191-21-006069
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-29 16:00:11
Reporting Period:
2021-01-27
Accepted Time:
2021-01-29 16:00:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1707502 Solid Biosciences Inc. SLDB Biological Products, (No Disgnostic Substances) (2836) 900943402
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1727410 Lynn Jennifer Ziolkowski C/O Solid Biosciences Inc.
141 Portland Street, Fifth Floor
Cambridge MA 02139
Cfo, Treasurer & Asst. Secy No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-01-27 11,500 $0.00 339,109 No 4 M Direct
Common Stock Disposition 2021-01-28 3,473 $6.14 335,636 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2021-01-27 11,500 $0.00 11,500 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
Footnotes
  1. Restricted Stock units convert into common stock on a one-for-one basis.
  2. This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units.
  3. On January 27, 2020, the reporting person was granted 23,000 restricted stock units, vesting in two equal installments. Fifty percent vested six months after the grant date with the remaining fifty percent vesting on the first anniversary of the grant date.